USPTO serial 50127726
INTRYX THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with INTRYX THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Fort Worth, TX, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw Hogan Lovells Cadwalader US LLP555 13th Street NWWASHINGTON, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treatment of cancer and oncological diseases and disorders | ACTIVE | — |
| 042 | Pharmaceutical products development; Providing medical and scientific information in the field of cancer and oncological diseases and disorders; providing information concerning biomedical research concerning the treatment of cancer and oncological diseases and disorders; scientific and medical research and development in the field of pharmaceuticals for treatment of cancer and oncological diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 24, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 24, 2026 | NWAP | NEW APPLICATION ENTERED | — |